About Us

Andrea Baccarelli, MD, PhD, is the Dean of the Faculty at the Harvard T.H. Chan School of Public Health. His work on the health impact of environmental exposures has been used by agencies worldwide to shape pollution control policies. Dr. Baccarelli previously served as chair of the Department of Environmental Health Sciences at Columbia Mailman School of Public Health, director of the NIH/NIEHS P30 Center for Environmental Health and Justice and president of the International Society for Environmental Epidemiology. He is a member of the National Academy of Medicine. Dr. Baccarelli holds an MD from the University of Perugia in Italy, an MS in Epidemiology from the University of Turin, and a PhD from the University of Milan.

I received my BA in English from Yale University in 1993 and my PhD in English from Harvard University in 2001. After teaching at Columbia University for nine years, I returned to Harvard in 2010. I am on the faculty of the English department, and for four years I chaired the program in History and Literature.

My scholarship focuses on nineteenth-century literature and history, with a particular attention to the role that teachers and writers play in times of social change. My first book, The Novel of Purpose: Literature and Social Reform in the Anglo-American World, was awarded the Rudikoff Prize in Victorian studies. Since then, I’ve continued to publish scholarly articles, but I also now write in more public venues, such as the London Review of Books, Public Books, and n+1. I’m currently finishing a work of narrative non-fiction, to be published by Farrar, Straus & Giroux, about the Union occupation of the South Carolina sea islands during the Civil War. To learn more about that project or about my scholarship and writing more generally, click here.

My teaching ranges widely, from Humanities 10 to the Gen Ed course I co-teach on the Civil War, but I find myself returning, again and again, to the novel. I teach courses on the 19th century novel, on the 21st century novel, on the historical novel, on the Bildungsroman. To learn more about my courses or about my teaching and advising more generally, click here.

George Q. Daley, MD, PhD, is the dean of Harvard Medical School and the Caroline Shields Walker Professor of Medicine. A physician-scientist and an authority on stem cell science and cancer biology, his discoveries have twice been cited in Science magazine’s Top 10 Breakthroughs of the Year. He has co-authored international guidelines for the conduct and clinical translation of stem cell research and regenerative medicine and for ethical oversight of emerging biotechnologies. Daley’s priorities as dean of HMS include fostering innovative biomedical, computational and health care policy research, building a pipeline of novel therapeutics founded on basic science, nurturing the next generation of physician-scientists and advancing diversity in science, technology, engineering and medicine. Daley earned his AB and MD degrees from Harvard and a PhD in biology from MIT, and has worked as a trainee, fellow and staff physician at several HMS‐affiliated hospitals.

John F. Manning is Harvard University’s Provost and the Dane Professor of Law at Harvard Law School. Manning was the Morgan and Helen Chu Dean and Professor of Law at Harvard Law School from 2017–2024. He joined the HLS faculty in 2004, and was the Bruce Bromley Professor of Law from 2007–2017 and Deputy Dean from 2013–2017. Prior to coming to Harvard, Manning was the Michael I. Sovern Professor of Law at Columbia Law School, where he began teaching in 1994. Manning teaches administrative law, federal courts, legislation and regulation, separation of powers, and statutory interpretation. His writing focuses on statutory interpretation and structural constitutional law. Manning is a co-editor of Hart & Wechsler’s Federal Courts and the Federal System (6th ed., 2009) (with Richard Fallon, Daniel Meltzer, and David Shapiro), and Legislation and Regulation (2d ed., 2013) (with Matthew Stephenson). Prior to entering teaching, Manning served as an assistant to the Solicitor General in the U.S. Department of Justice (1991–94), an associate in the D.C. office of Gibson, Dunn & Crutcher (1989–91), and an attorney-advisor in the Office of Legal Counsel in the U.S. Department of Justice (1986–88). He served as a law clerk to Hon. Antonin Scalia on the Supreme Court of the United States (1988–89) and to Hon. Robert H. Bork on the U.S. Court of Appeals for the D.C. Circuit (1985–86). Manning graduated from Harvard Law School in 1985 and Harvard College in 1982. He is a member of the American Academy of Arts and Sciences.

Marcella Alsan is a physician-economist studying the economics of health inequality domestically and internationally. Alsan received a BA from Harvard University, a master’s in public health from Harvard School of Public Health, a MD from Loyola and a PhD in Economics from Harvard. She trained at Brigham and Women’s Hospital Howard Hiatt Global Health Equity Residency Fellowship – then combined the PhD with an Infectious Disease Fellowship at Massachusetts General Hospital. Prior to returning to Harvard she was tenured at Stanford. She is Associate Editor at the Journal of Economic Literature and Co-Chair of the Health Care Delivery Initiative of Abdul Latif Jameel Poverty Action Lab at MIT. She is co-recipient of the 2019 Arrow Award for Best Paper in Health Economics, the 2021 William G. Manning Memorial Award for the Best Research in Health Econometrics, recipient of a MacArthur Fellowship and was elected into the National Academy of Medicine in 2022. She co-directs the Health Inequality Lab at Harvard Kennedy School of Government.

Dr. Satchit Balsari is Associate Professor in Emergency Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center; and in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. Dr. Balsari’s research and teaching are focused on complex humanitarian emergencies and digital health implementation science in resource-poor settings. He has worked with populations affected by disaster, war and the COVID-19 pandemic in Iraq, South Sudan, Jordan, Haiti, Puerto Rico and across South Asia. In the most vulnerable communities in the world, his team has leveraged cutting-edge digital tools and citizen science to advance public health planning, advocacy and response.

The Balsari Lab collaborates directly with populations in distress, humanitarian response agencies, civil society organizations, governments, and international agencies, to reduce the information asymmetry that threatens to exclude the poor and disadvantaged from decisions that will impact their lives. Dr. Balsari co-directs CrisisReady.io, a research-response platform that builds data-driven decision tools for local communities and response agencies affected by disasters globally. Dr. Balsari is founding director of the tri-institute Climate and Human Health fellowship at Harvard, leads the climate platform at the Mittal Institute, and is co-investigator on the Salata Institute’s inaugural interfaculty cluster grant on Climate Change Adaptation in South Asia.

Dr. Balsari is currently curating a traveling exhibition Hum Sab Ek, on the impact of the pandemic on the lives and livelihoods of the working poor in India, and the tools of organization and collective bargaining used by them to navigate the greatest public health emergency of our times.

He is affiliate faculty at the Department of Global Health and Social Medicine at HMS, the Center for International Development at the Kennedy School, the Harvard University Center for the Environment, the Harvard Salata Institute for Climate and Sustainability, the Harvard Data Science Initiative, and the Harvard FXB Center for Health and Human Rights.

Prior signature initiatives include EMcounter (a customizable, portable digital surveillance tool, the latest iteration of which was used at the world’s largest mass gathering, the Kumbh Mela in India) and Voices, a crowd-sourced, online disaster response analysis tool. In 2018, in collaboration with Professor Caroline Buckee (Epidemiology), he co-led the Hurricane Maria Mortality Study.

In March 2017, Pranab Mukherjee, President of India, awarded him India’s highest honor in medicine, the Dr B.C. Roy National Award for “outstanding services in the field of sociomedical relief.” Dr. Balsari has also been an Aspen Ideas Scholar (2016) and an Asia 21 Fellow of the Asia Society. Dr. Balsari received his medical degree from Grant Medical College in Mumbai, India and his public health degree from Harvard; he completed his emergency medicine residency at Columbia and Cornell’s New York-Presbyterian Hospital, where he was chief of the global emergency medicine division, until 2017.

Dr. Sara Bleich is the inaugural Vice Provost for Special Projects at Harvard University, director of the social sciences program and Carol K. Pforzheimer Professor at Harvard Radcliffe Institute, Professor of Public Health Policy at the Harvard T.H. Chan School of Public Health, and a faculty member at the Harvard Kennedy School of Government. With more than 180 peer-reviewed publications, she is a policy expert and researcher who specializes in diet-related diseases, food insecurity, and racial inequality. Prior to this, Dr. Bleich served in the Biden Administration as the Director of Nutrition Security and Health Equity at the U.S. Department of Agriculture (USDA) Food and Nutrition Service and as the Senior Advisor for COVID-19 in the Office of the Secretary at USDA. As a White House Fellow during the Obama Administration, she worked at USDA as a Senior Policy Adviser for Food, Nutrition and Consumer Services and on First Lady Michelle Obama’s Let’s Move! initiative. Dr. Bleich was elected to the National Academy of Medicine in 2023 and holds a B.A. in psychology from Columbia University and a PhD in health policy from Harvard University.

Dr. Cohen is a health and behavioral economist whose research uses randomized controlled trials and other rigorous quasi-experimental methods to evaluate the impact of maternal and child health programs and policies, both in the United States and East African countries. Dr. Cohen’s research explores the behavioral channels by which health policies translate into health outcomes, with the aim of embedding this evidence into policy design and increasing policy impact. Dr. Cohen has conducted randomized controlled trials to evaluate the impact of incentives, subsidies, information, and decision architecture on health seeking behavior and health outcomes in the domains of malaria and maternal health from the prenatal through the postnatal period. Her research uses concepts from economics and psychology to explore drivers of critical health behaviors including maternity care seeking, postpartum contraception, and child nutrition. She also has used various quasi-experimental designs to evaluate the impact of large health policy and health system changes on population health, including malaria pharmaceutical subsidy policies and maternity provider payment models. Current work explores drivers of maternity provider behavior, including quality of care during labor and delivery and provision of postpartum contraception.

Dr. Cohen’s work has been published widely in top economics and public health journals and has been referenced in major national and international publications. She has won a mentorship award and a teaching award from the Harvard T. H. Chan School of Public Health. Her research on subsidy policies for insecticide treated nets was deemed by Vox as a top social science paper of the decade. Dr. Cohen was a member of the WHO Global Malaria Program’s Technical Expert Group on Surveillance, Monitoring and Evaluation and has served on NIH expert review panels related to implementation science and impact evaluation.

Dr. Cohen received her bachelor’s degree in Economics from Wesleyan University and her PhD in Economics from MIT, where she was a National Science Foundation Graduate Research Fellow.

David Cutler has developed an impressive record of achievement in both academia and the public sector. He served as Assistant Professor of Economics from 1991 to 1995, was named John L. Loeb Associate Professor of Social Sciences in 1995, and received tenure in 1997. He is currently the Otto Eckstein Professor of Applied Economics in the Department of Economics and was named Harvard College Professor in 2014 until 2019. Professor Cutler holds secondary appointments at the Kennedy School of Government and the School of Public Health. Professor Cutler was associate dean of the Faculty of Arts and Sciences for Social Sciences from 2003-2008.

Honored for his scholarly work and singled out for outstanding mentorship of graduate students, Professor Cutler’s work in health economics and public economics has earned him significant academic and public acclaim. Professor Cutler served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration and has advised the Presidential campaigns of Bill Bradley, John Kerry, and Barack Obama as well as being Senior Health Care Advisor for the Obama Presidential Campaign. Among other affiliations, Professor Cutler has held positions with the National Institutes of Health and the National Academy of Sciences. Currently, Professor Cutler is a Research Associate at the National Bureau of Economic Research and a member of the National Academy of Medicine. He advises many companies and groups on health care.

Professor Cutler was a key advisor in the formulation of the recent cost control legislation in Massachusetts, and is one of the members of the Health Policy Commission created to help reduce medical spending in that state. Professor Cutler is author of three books, several chapters in edited books, and many published papers on the topics of Author of Your Money Or Your Life: Strong Medicine for America’s Health health care and other public policy topics. Care System, published by Oxford University Press, this book, and Professor Cutler’s ideas, were the subject of a feature article in the New York Times Magazine, The Quality Cure, by Roger Lowenstein. Cutler recently completed a book, Survival of the City: The Future of Urban Life in an Age of Isolation (with Edward Glaeser), examining how cities need to and can adapt to pandemics and other threats.

Professor Cutler received an AB from Harvard University (1987) and a PhD in Economics from MIT (1991).

Mark Elliott is Vice Provost of International Affairs at Harvard University and the Mark Schwartz Professor of Chinese and Inner Asian History in the Department of East Asian Languages and Civilizations and the Department of History.

Elliott is an authority on the last four centuries of Chinese history, particularly the Qing period (1636-1911). His research encompasses the history of relations between China and its nomadic frontier, focusing on questions of ethnicity, institutions, and empire. An expert in Manchu studies, he is known as a pioneering figure in the New Qing History which emphasizes the imprint of Inner Asian traditions upon China’s last imperial state.

As vice provost, Elliott oversees and works to advance international academic initiatives, extending the global reach of Harvard’s research and teaching activities. He also guides Harvard’s overall global strategy, sustaining its ongoing development as a global university and supporting its community of international students, scholars, faculty in Cambridge and Boston as well as alumni around the world.

A graduate of Yale, Elliott earned his PhD in History at the University of California, Berkeley. He has taught at Harvard since 2003.

Sue J Goldie is the Roger Irving Lee Professor of Public Health and serves as the Director of both the Center for Health Decision Science, Harvard T.H. Chan School of Public Health (2009- ) and the Global Health Education and Learning Incubator at Harvard University (2015- ). She served as the founding Director of the Harvard Global Health Institute (2010-2015).

Her research has influenced clinical guidelines, health policy, and priority setting in low, middle and high-income countries. She was awarded a MacArthur grant “for genius and creativity” (2005) in applying decision analytic methods to public health, the John Eisenberg Award for translation of research to practice (2008), and was elected to the National Academy of Sciences (2009).

Goldie has catalyzed cross-sectoral collaboration beyond the university, played key roles in initiatives such as the Lancet Commission on Investing in Health, and infused global health perspectives into educational opportunities across schools. Piloting creative pedagogy, Goldie has developed courses in decision science and population health for undergraduates and graduates, and has received more than a dozen teaching and mentorship awards.

Dr. Goldie attended Union College (BS, 1984), Albany Medical College (MD, 1988, Alpha Omega Alpha Honor Medical Society), Yale University School of Medicine (Internal Medicine, 1988-1991), and the Harvard T. H. Chan School of Public Health (MPH, 1997). She joined the faculty in 1998 and received tenure in 2006.

Dr. Kerry is the co-founder and CEO of Seed Global Health, a non-profit organization focused on health systems strengthening and transformation through long-term investments and training of the health workforce. Under her leadership, Seed has helped educate more than 34,000 doctors, nurses, and midwives in seven countries, helping to improve health care for more than 73 million people.

In June 2023, Dr. Kerry was appointed WHO Special Envoy for Climate Change and Health. She has spoken and written about the effects of climate change on human health and health systems and the need to integrate a health-centered response into climate change mitigation and adaptation measures. Dr. Kerry supported the UAE COP28 Presidency to shape the first-ever COP Day of Health on December 3, 2023 and continues to lead efforts globally to build advocacy around the impact of climate change on health and ensure equitable and just climate action.

As co-chair of a workstream on the World Health Organization’s Public Health and Emergency Health Workforce Roadmap, she is helping to galvanize consensus for investment in surveillance, detection, and treatment for the next pandemic.

She is a critical care physician at Massachusetts General Hospital (MGH) and serves as the associate director of partnerships and global initiatives at the MGH Center for Global Health. She directs the Global Public Policy and Social Change program at Harvard Medical School where she has focused on links between security and health. She is the mother of two children.

M. William Lensch, Ph.D., is Associate Provost for Research. In this role, he works closely with the Vice Provost for Research (VPR) to support Harvard’s rich and complex, investigator-driven enterprise. His experience in research, education, administration, science policy, intellectual property, consulting and outreach combine in support of scientific discovery. He oversees a variety of strategic initiatives and develops key relationships – both within and beyond Harvard – to advance this research agenda including the many Interfaculty Initiatives (IFI) and cross-school curricular programs.

Prior to assuming his current role, Dr. Lensch was Strategic Advisor to the Dean of Harvard Medical School (HMS) and Executive Director of the Massachusetts Consortium on Pandemic Readiness (MassCPR), an HMS-led, multi-institutional response to the global COVID-19 pandemic. He has additionally served the Harvard community as Chief of Staff to the Dean of the Faculty of Medicine, Executive Director of the Department of Stem Cell and Regenerative Biology (SCRB), Faculty Director of Education for the Harvard Stem Cell Institute (HSCI), and as Instructor in Pediatrics at HMS/Boston Children’s Hospital.

He has contributed to more than 60 peer-reviewed articles, reviews, book chapters and policy recommendations, and presented over 200 lectures, medical grand rounds, interviews and panel discussions.

Dr. Lensch earned his B.S. in Biology from Utah State University and his Ph.D. in the Department of Molecular and Medical Genetics at Oregon Health Sciences University, where he studied pediatric bone marrow failure, the onset of myeloid leukemia and rare diseases of the blood. His post-doctoral work at the Whitehead Institute for Biomedical Research and as a Leukemia and Lymphoma Society Career-Development Fellow at Boston Children’s Hospital used various types of human cells and tissue as platforms for understanding the genetics, development and diseases of the blood-forming system.

Dr. Shahin Lockman is Associate Professor at Brigham and Women’s Hospital and at the Harvard T.H. Chan School of Public Health. She completed her medical degree at Northwestern University, residency at Beth Israel Hospital Boston, infectious disease fellowship at the Brigham and Women’s Hospital and Massachusetts General Hospital combined fellowship program, and was an Epidemic Intelligence Service officer at the CDC.

She has conducted clinical trials, epidemiologic and implementation science investigation related to HIV-1 in Botswana since 1996. One of her research focus areas is clinical trials evaluating the safety and efficacy of antiretroviral drugs used for HIV treatment and prevention among pregnant and postpartum women. She also conducts research on neurodevelopmental and health and outcomes in HIV-exposed, uninfected children, and community-based HIV treatment and prevention interventions. Dr. Lockman mentors early stage investigators, primarily from Botswana and the region, on clinical HIV research projects; she is a multiple PI of the Botswana Clinical Trials Unit at the Botswana Harvard AIDS Institute Partnership, which conducts NIH network clinical trials related to HIV (through the ACTG, IMPAACT, HPTN, and CoVPN networks); and of the Botswana Fogarty HIV Research Training Grant.

Dr. McCluskey is an Assistant Professor at Harvard Medical School and an Assistant in Medicine in the Division of Infectious Diseases at Massachusetts General Hospital, where she also serves as the Chair of the Global Health Research Collaborative and as Faculty in the Medical Practice Evaluation Center. She received her MD from the University of Alabama at Birmingham School of Medicine. Dr. McCluskey’s research program focuses on the epidemiology and management of HIV treatment failure and antiretroviral drug resistance in resource-limited settings with projects based in Mbarara, Uganda and KwaZulu Natal, South Africa.

Megan Murray is an epidemiologist and an infectious disease physician, with over 25 years of experience studying tuberculosis and other infectious diseases. She received her MD from Harvard Medical School in 1990 and completed her residency in internal medicine and a fellowship in Infectious Disease at Massachusetts General Hospital. She received her ScD in Epidemiology from the Harvard School of Public Health in 2000. She currently serves as the Ronda Stryker and William Johnston Professor of Global Health and Social Medicine at Harvard Medical School and as a Professor of Epidemiology at the Harvard Chan School of Public Health.

Dr. Murray’s research focuses on social, host and pathogen specific determinants of TB infection, disease and treatment outcomes. She studies nutritional risk factors for TB infection and disease, including macronutrients status and the role of Vitamins A, E and D. She uses bacterial and human genetic and genomic tools to identify variants of interest and their role in TB.

Ruth L. Okediji is the Jeremiah Smith. Jr, Professor of Law at Harvard Law School and Co-Director of the Berkman Klein Center. A renowned scholar in international intellectual property (IP) law and a foremost authority on the role of intellectual property in social and economic development, Professor Okediji has advised inter-governmental organizations, regional economic communities, and national governments on a range of matters related to technology, innovation policy, and development. Her widely cited scholarship on IP and development has influenced government policies in sub-Saharan Africa, the Caribbean, Latin America, and South America. Her ideas have helped shape national strategies for the implementation of the WTO’s Agreement on Trade- Related Aspects of Intellectual Property Rights (TRIPS Agreement). She works closely with several United Nations agencies, research centers, and international organizations on the human development effects of international IP policy, including access to knowledge, access to essential medicines and issues related to indigenous innovation systems.

Professor Okediji was a member of the United States National Academies’ Board on Science, Technology and Policy Committee on the Impact of Copyright Policy on Innovation in the Digital Era. She served as the Chief Technical Expert and Lead Negotiator for the Delegation of Nigeria to the 2013 WIPO Diplomatic Conference to Conclude a Treaty to Facilitate Access to Published Works by Visually Impaired Persons and Persons with Print Disabilities (Marrakesh VIP Treaty). Okediji was appointed by United Nations Secretary-General Ban Ki-moon to the 2015 – 2016 High Level Panel on Access to Medicines.

Professor Okediji is a recipient of numerous awards for excellence in teaching, research and mentoring. She is an editor of the Journal of World Intellectual Property Law and an elected member of the American Law Institute. Her most recent book, Copyright Law in an Age of Limitations and Exceptions, was published by Cambridge University Press in 2017.

Professor Okediji is a graduate of the University of Jos and Harvard Law School.

Dr. Riviello is the medical director of the metabolic support service and an associate surgeon with the Division of Trauma, Burn and Surgical Critical Care and Emergency General Surgery at Brigham and Women’s Hospital. He is also the chair of the University of Global Health Equity in Rwanda and the Kletjian Distinguished Chair in Global Surgery in the Department of Surgery at Brigham and Women’s Hospital.

Dr. Riviello received his bachelor’s degree from Harvard College, his master’s degree from the Harvard School of Public Health and his medical degree from the University of California. He completed his general surgery residency at Vanderbilt University. He completed the Fulbright International Fellowship in Global Surgery at Centro Evangelico de Medicina do Lubango in Angola and a research fellowship in global surgery at the Brigham and Women’s Hospital Center for Surgery and Public Health. He completed an acute care and burn surgery fellowship, as well as an anesthesia critical care medicine fellowship at Brigham and Women’s Hospital.

Alicia Ely Yamin JD MPH PhD is a Lecturer on Law and the Senior Fellow on Global Health and Rights at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School; Adjunct Senior Lecturer on Health Policy and Management at the Harvard TH Chan School of Public Health; and Senior Advisor on Human Rights and Health Policy at the global health justice organization, Partners In Health.

Known globally for her trans-disciplinary work in relation to economic and social rights, sexual and reproductive health and rights, the right to health, and the intersections between development paradigms and human rights, Yamin’s career has bridged academia and activism. She has lived in Latin America and East Africa for much of her professional life and worked with local advocacy organizations, including co-founding a program on health and human rights in the Asociación Pro Derechos Humanos (Lima, Peru; 1999).

Yamin was appointed by the UN Secretary General as one of ten international experts to the Independent Accountability Panel for Women’s, Children’s and Adolescents’ Health in the Sustainable Development Goals (2016-2021). She was the chief consultant to the Office of the High Commissioner for Human Rights and drafter of the ‘Technical guidance on the application of a human-rights based approach to the implementation of policies and programmes to reduce preventable maternal morbidity and mortality’, the first guidance on a ‘human rights-based approach to health’ to be adopted by the UN Human Rights Council.

Yamin has served on numerous other UN, WHO and other global expert committees. She currently serves on the WHO’s Technical Advisory Group on Health Technology Assessments; the WHO Global Advisory Group on Legislating Maternal Perinatal Death Surveillance; the joint World Bank/Norwegian Institute for Public Health/Bergen Centre on Ethics and Priority Setting project on ‘Health Financing for Universal Health Coverage’; the Lancet Commission on Arctic and Northern Health; and as Co-Chair on the Interim Steering Committee of the Global Public Investment Network (GPIN).

In 2011, Yamin was named by the Colombian Constitutional Court as an Independent Expert on the implementation of T- 760/08, a major structural judgment that led to significant health system reform In Colombia. She was also the only non- Kenyan appointed to the oversight committee for health matters of the Constitutional Implementation Commission in relation to the 2010 Kenyan Constitution.

Yamin regularly provides testimony and guidance to tribunals and legislative bodies around the globe, as well as amicus curiae briefs, in relation to the application of international and comparative law to health and sexual and reproductive rights issues.

From 2009-2015, Yamin served as Chair of the Board of the Center for Economic and Social Rights (Vice-Chair, 2001-08). She is a current and founding member of the Global Health Law Consortium; a Senior Associated Researcher of the Centre on Law and Social Transformation (Norway); and a Board member of the global organization, Women in Global Health. In Argentina, Yamin sits on the international advisory boards of the RedAAS (Argentine Safe Abortion Access Network) and the Proyecto Mirar (monitoring implementation of Law 27.610, which legalized first trimester abortion).

Yamin holds Juris Doctor and Master’s in Public Health degrees from Harvard University, and a Doctorate in Law from the University of Buenos Aires in Argentina. She has published multiple books and over 160 articles in law and policy journals, as well as peer-reviewed public health journals, in both English and Spanish. A revised and substantially expanded edition of her latest monograph, When Misfortune becomes Injustice: Evolving Human Rights Struggles for Health and Social Equality, is due out from Stanford University Press in 2023.